Identify the patient subgroup most likely to develop motor fluctuations (young patients on high cumulative levodopa) and start preventive dose adjustments before fluctuations become disabling. Perform a complete medication audit in any patient presenting subacutely with new parkinsonism, as metoclopramide for gastroparesis is frequently overlooked in diabetics.

Introducing amantadine is a highly effective clinical strategy for suppressing these peak-dose movements; We tend to see this complication emerge most frequently and severely in younger women; For managing these specific off-period dystonic episodes, a medication referred to as R-10 can be tried as a therapeutic option; On average, after about two to three years of steady levodopa therapy, a significant number of individuals will begin experiencing these fluctuations in their clinical response; During a wearing-off period, an individual might experience severe anxiety, profound fatigue, urinary frequency, generalized pain, or vague sensory complaints like numbness and paresthesias